PD-1 targeted immunotherapy for advanced hepatocellular cancer: Current utilization and outcomes in the United States.

e16647Background: Novel oncological treatment strategies for hepatocellular carcinoma (HCC) include immunotherapies targeting programmed death protein 1 (PD-1). To date there is scarce data on the ...